Florian Abel

449 total citations
16 papers, 325 citations indexed

About

Florian Abel is a scholar working on Physiology, Pediatrics, Perinatology and Child Health and Physiology. According to data from OpenAlex, Florian Abel has authored 16 papers receiving a total of 325 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Physiology, 8 papers in Pediatrics, Perinatology and Child Health and 5 papers in Physiology. Recurrent topics in Florian Abel's work include Lysosomal Storage Disorders Research (10 papers), Neonatal Health and Biochemistry (8 papers) and Calcium signaling and nucleotide metabolism (5 papers). Florian Abel is often cited by papers focused on Lysosomal Storage Disorders Research (10 papers), Neonatal Health and Biochemistry (8 papers) and Calcium signaling and nucleotide metabolism (5 papers). Florian Abel collaborates with scholars based in United States, United Kingdom and Italy. Florian Abel's co-authors include Frank Thielecke, Stefanie Maxion‐Bergemann, R Bergemann, Sachin Marulkar, Victoria Kolb‐Bachofen, Peré Domingo, Renato Maserati, Armin Rieger, Hui Wang and Georg M. N. Behrens and has published in prestigious journals such as Journal of Hepatology, Carbohydrate Research and Journal of Pediatric Gastroenterology and Nutrition.

In The Last Decade

Florian Abel

12 papers receiving 314 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Florian Abel United States 8 178 100 75 46 35 16 325
Jarosław Kwiecień Poland 12 163 0.9× 56 0.6× 163 2.2× 12 0.3× 29 0.8× 42 388
François Dyard France 10 232 1.3× 94 0.9× 227 3.0× 18 0.4× 97 2.8× 15 552
George L. Arnold United States 6 146 0.8× 64 0.6× 93 1.2× 34 0.7× 47 1.3× 9 345
Jürgen Gschossmann Germany 11 137 0.8× 44 0.4× 99 1.3× 16 0.3× 87 2.5× 14 317
John Keohane Ireland 12 360 2.0× 50 0.5× 271 3.6× 42 0.9× 63 1.8× 28 617
Margaret K. Breen‐Lyles United States 10 155 0.9× 65 0.7× 104 1.4× 75 1.6× 70 2.0× 19 342
Frances Dang Canada 6 286 1.6× 167 1.7× 90 1.2× 13 0.3× 118 3.4× 17 448
Nuha Alammar Saudi Arabia 5 198 1.1× 75 0.8× 165 2.2× 27 0.6× 96 2.7× 6 384
Navya D. Kanuri United States 9 195 1.1× 55 0.6× 139 1.9× 13 0.3× 107 3.1× 17 485
Lars Kjellström Sweden 11 223 1.3× 75 0.8× 133 1.8× 39 0.8× 76 2.2× 17 413

Countries citing papers authored by Florian Abel

Since Specialization
Citations

This map shows the geographic impact of Florian Abel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Florian Abel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Florian Abel more than expected).

Fields of papers citing papers by Florian Abel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Florian Abel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Florian Abel. The network helps show where Florian Abel may publish in the future.

Co-authorship network of co-authors of Florian Abel

This figure shows the co-authorship network connecting the top 25 collaborators of Florian Abel. A scholar is included among the top collaborators of Florian Abel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Florian Abel. Florian Abel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Vijay, Suresh, et al.. (2025). Survival achieved in infants with rapidly progressive LAL-D via sebelipase alfa ERT: Results from the International LAL-D Registry. Molecular Genetics and Metabolism. 144(2). 108971–108971.
2.
D’Antiga, Lorenzo, Jennifer Evans, Emilio Ros, et al.. (2025). Sebelipase Alfa Improves Aminotransferase Levels in Lysosomal Acid Lipase Deficiency: Data From an International Registry. Liver International. 45(9). e70279–e70279. 1 indexed citations
3.
4.
Balwani, Manisha, William F. Balistreri, Lorenzo D’Antiga, et al.. (2023). Lysosomal acid lipase deficiency manifestations in children and adults: Baseline data from an international registry. Liver International. 43(7). 1537–1547. 5 indexed citations
5.
Burton, Barbara K., et al.. (2022). Long‐Term Sebelipase Alfa Treatment in Children and Adults With Lysosomal Acid Lipase Deficiency. Journal of Pediatric Gastroenterology and Nutrition. 74(6). 757–764. 11 indexed citations
6.
7.
Vijay, Suresh, Anaïs Brassier, Arunabha Ghosh, et al.. (2021). Long-term survival with sebelipase alfa enzyme replacement therapy in infants with rapidly progressive lysosomal acid lipase deficiency: final results from 2 open-label studies. Orphanet Journal of Rare Diseases. 16(1). 13–13. 18 indexed citations
8.
Vijay, Suresh, Anaïs Brassier, Arunabha Ghosh, et al.. (2021). Correction to: Long-term survival with sebelipase alfa enzyme replacement therapy in infants with rapidly progressive lysosomal acid lipase deficiency: final results from 2 open-label studies. Orphanet Journal of Rare Diseases. 16(1). 113–113. 10 indexed citations
9.
Malinová, Vĕra, Manisha Balwani, Reena Sharma, et al.. (2020). Sebelipase alfa for lysosomal acid lipase deficiency: 5‐year treatment experience from a phase 2 open‐label extension study. Liver International. 40(9). 2203–2214. 15 indexed citations
10.
Burton, Barbara K., et al.. (2019). PS-196-Efficacy and safety of sebelipase alfa over 144 weeks in a diverse population of children and adults with lysosomal acid lipase deficiency. Journal of Hepatology. 70(1). e121–e122. 1 indexed citations
11.
12.
Abel, Florian, et al.. (2014). The microenvironment in the human lung partly determines the site of the first metastasis.. PubMed. 34(7). 3845–9. 2 indexed citations
13.
Behrens, Georg M. N., Renato Maserati, Armin Rieger, et al.. (2012). Switching to Tenofovir/Emtricitabine from Abacavir/ Lamivudine in HIV-Infected Adults with Raised Cholesterol: Effect on Lipid Profiles. Antiviral Therapy. 17(6). 1011–1020. 41 indexed citations
14.
Maxion‐Bergemann, Stefanie, Frank Thielecke, Florian Abel, & R Bergemann. (2006). Costs of Irritable Bowel Syndrome in the UK and US. PharmacoEconomics. 24(1). 21–37. 200 indexed citations
15.
Thielecke, Frank, et al.. (2004). Update in the pharmaceutical therapy of the irritable bowel syndrome. International Journal of Clinical Practice. 58(4). 374–381. 7 indexed citations
16.
Kolb‐Bachofen, Victoria & Florian Abel. (1991). Participation of d-galactose-specific receptors of liver macrophages in recognition of fibronectin-opsonized particles. Carbohydrate Research. 213. 201–213. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jarosław Kwiecień Breakdown of academic impact, for papers by François Dyard Breakdown of academic impact, for papers by George L. Arnold Breakdown of academic impact, for papers by Jürgen Gschossmann Breakdown of academic impact, for papers by John Keohane Breakdown of academic impact, for papers by Margaret K. Breen‐Lyles Breakdown of academic impact, for papers by Frances Dang Breakdown of academic impact, for papers by Nuha Alammar Breakdown of academic impact, for papers by Navya D. Kanuri Breakdown of academic impact, for papers by Lars Kjellström
Rankless by CCL
2026